(MedPage Today) — The FDA plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products…
Source link : https://www.medpagetoday.com/publichealthpolicy/clinicaltrials/119944
Author :
Publish date : 2026-02-19 15:20:00
Copyright for syndicated content belongs to the linked Source.
